During the past decade, Earle Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Earle Research" are "Depressive Disorder, Major" (4 trials), "Borderline Personality Disorder" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Earle Research" in a lesser frequency.

Most popular intervention types in "Earle Research" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rapastinel" (4 trials), "Placebo" (2 trials), "Atogepant" (1 trials), "Brexpiprazole" (1 trials) and "Placebo-matching Rapastinel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Earle Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Earle Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Earle Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Earle Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".